Positive (fibroblasts) → poor prognosis (shorter relapse-free survival) in luminal A breast cancerPositive (MICs) → poor prognosis (shorter relapse-free survival) in HER2-positive breast cancer. This evidence concerns the gene ERBB2 and breast cancer.